Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.53 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.53 |
| ▸ | OR51E2 | Q9H255 | 3/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.47 |
| ▸ | FEN1 | P39748 | 6/20 | 0.40 |
| ▸ | ERCC5 | P28715 | 5/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HAO1 | Q9UJM8 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxaloacetate SCHEMBL6545252 | 1.00 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL8464 | 0.96 | — | — | |
| Oxaloacetate SCHEMBL4298763 | 0.96 | LDHA (0.57) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL898612 | 0.96 | LDHA (0.57) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL25210523 | 0.93 | — | — | |
| Oxaloacetate SCHEMBL8638879 | 0.93 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL9994505 | 0.93 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL9782818 | 0.93 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL20912993 | 0.93 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL11328361 | 0.93 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105603015-B | A kind of production method of L-glufosinate-ammonium | 浙江大学 | 2018-12-11 | — | — | CN | disclosed |
| CN-108893455-A | A kind of transaminase mutant and its application for producing L-glufosinate-ammonium | 浙江工业大学 | 2018-11-27 | — | — | CN | disclosed |
| US-9783840-B2 | Decalcification solution with preservation of RNA | JACQUET ROBIN DIFEO (US) | 2017-10-10 | — | — | US | disclosed |
| CN-107119084-A | A kind of method that utilization transaminase and ethylene synthetase produce L glufosinate-ammoniums | 浙江大学 | 2017-09-01 | — | — | CN | disclosed |
| US-20160289743-A1 | DECALCIFICATION SOLUTION WITH PRESERVATION OF RNA | THE UNIVERSITY OF AKRON (US) | 2016-10-06 | — | — | US | disclosed |
| US-9383297-B2 | Decalcification solution with preservation of RNA | THE UNIVERSITY OF AKRON (US) | 2016-07-05 | — | — | US | disclosed |
| US-20040170598-A1 | Polysaccharide -polypeptide polymer; antiinflammatory agents, immunomoderators; culture product; applying stresses; anticancer agents; aids therapy | GRANADA BIO TECH, S.A. DE C.V. (MX) | 2004-09-02 | — | — | US | disclosed |
| EP-1373540-A1 | POLYSUBSTITUTED POLYCARBOXYLIC PHOSPHOAMIDE BIOPOLYMERS, METHODS FOR THEIR PRODUCTION AND USES OF COMPOSITIONS DERIVED THEREFROM | Granada Bio Tech SA DE CV (MX) | 2004-01-02 | — | — | EP | disclosed |
| CN-1415760-A | Transfer related gene | ACADEMY OF TAIWAN UNIV (CN) | 2003-05-07 | — | — | CN | disclosed |
| WO-2002081720-A1 | POLYSUBSTITUTED POLYCARBOXYLIC PHOSPHOAMIDE BIOPOLYMERS, METHODS FOR THEIR PRODUCTION AND USES OF COMPOSITIONS DERIVED THEREFROM | GRANADA BIO TECH SA DE CV (MX) | 2002-10-17 | — | — | WO | disclosed |
| US-4267268-A | Spermatozoa extenders | OLD STONE BANK, A RHODE ISLAND BANKING CORP. | 1981-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040170598-A1 | Polysaccharide -polypeptide polymer; antiinflammatory agents, immunomoderators; culture product; applying stresses; anticancer agents; aids therapy | PGAM1, PGM2, PGAM5 | LDHA 763/4885SRR 2975/4885OR51E2 4115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.